MOG encephalomyelitis: international recommendations on diagnosis and antibody testingSven Jarius, Brigitte Wildemann, Friedemann Paul et al.|Journal of Neuroinflammation|2018Cited by 740
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trialBruce Cree, Eliezer Katz, Jeffrey L. Bennett et al.|The Lancet|2019Cited by 722
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysisAxel Petzold, Bernhard Hemmer, Laura J. Balcer et al.|The Lancet Neurology|2017Cited by 572
Myelin-oligodendrocyte glycoprotein antibody-associated diseaseRomain Marignier, Bernhard Hemmer, Yael Hacohen et al.|The Lancet Neurology|2021Cited by 518
Worldwide Incidence and Prevalence of Neuromyelitis OpticaViktoria Papp, Zsolt Illés, Melinda Magyari et al.|Neurology|2020Cited by 303